Skip to main content

Purine Nucleotide Imbalance in Immunodeficiency Disorders

  • Chapter

Part of the book series: Basic Life Sciences ((BLSC,volume 31))

Abstract

In 1972, Dr Hilaire Meuwissen of Albany, New York, sent some blood samples to Eloise Giblett of the Puget Sound Blood Center, Seattle, Washington, for analysis of genetic markers. One of the blood samples was from a patient with severe combined immunodeficiency disease and the other samples were from the patient’s parents Dr. Meuwissen was prepared to perform a bone marrow transplant in the patient and in preparation for the eventual necessity of documenting cell chimerism, was attempting to obtain as many genetic markers as possible to prove establishment of a bone marrow graft. Much to Dr. Giblett’s surprise, one of the enzymes, adenosine deaminase (ADA) (EC 3.5.4.4) was absent while the parents had approximately one-half normal activity. Several weeks later, Dr. Flossie Cohen of Detroit sent a blood specimen to Dr. Giblett from an additional patient with severe combined immunodeficiency disease. This patient also lacked ADA activity, while the parents had levels lower than normal. In 1973, a symposium on ADA deficiency and severe combined immunodeficiency disease was held in Albany, New York. After a careful review of laboratory and biochemical data, it was determined that 12 of 22 patients with SCID who had been tested for ADA activity in North American and Western Europe were ADA-deficient. Also in 1973, Jenkins reported finding a !Kung aborigine boy with absent red cell ADA activity but with normal function. Subsequently it was determined that the patient’s lymphocytes and fibroblasts had 10–30% of normal ADA activity. Recent reviews summarize these and additional cases [24].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. J. Ammann, in: “Enzyme Defects and Immune Dysfunction,” Ciba Foundation Symposium 68, p. 55, Excerpta Medica, Amsterdam.

    Google Scholar 

  2. A. J. Ammann, D. W. Wara, and T. Allen, Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency, Clin. Immunol, and Immunopathol., 10:262–269 (1978).

    Google Scholar 

  3. A. J. Ammann, D. W. Wara, and T. Allen, Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency, Clin. Immunol, and Immunopathol., 10:262–269 (1978).

    Google Scholar 

  4. W. D. Biggar, E. R. Giblett, R. L. Ozere, and B. D. Grove, A new form of nucleoside phosphorylase deficiency in two brothers with defective T-cell function, J. Pediatr., 92:354–357 (1978).

    Google Scholar 

  5. W. Borkowsky, A. A. Gerson, L. Shenkman, and R. Hirschhorn, Adenosine deaminase deficiency without immunodeficiency: Clinical and metabolic studies, Pediatr. Res., 14:885–889 (1980).

    Google Scholar 

  6. E. Carapella-de Luca, F. Aiuti, P. Lucarelli, L. Bruni, and C. D. Baroni, C. Imperato, D. Roos, and A. Astaldi, A patient with nucleoside phosphorylase deficiency, selective T-cell deficiency, and autoimmune hemolytic anemia, J. Pediatr., 93: 1000–1003 (1978).

    Google Scholar 

  7. D. A. Carson, J. Kaye, and J. E. Seegmiller, Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(a), Proc. Natl. Acad. Sci., U.S.A., 74:5677–5681 (1977).

    Google Scholar 

  8. D. A. Carson, J. Kaye, and D. B. Wasson, Differences in deoxy- adenosine metabolism in human and mouse lymphocytes, J. Immunol., 124:8–12 (1980).

    Google Scholar 

  9. D. A. Carson, J. Kaye, and D. B. Wasson, The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts, J. Immunol., 126: 348–352 (1981).

    Google Scholar 

  10. A. Cohen, D. Doyle, D. W. Martin, Jr., and A. J. Ammann, Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase, N. Engl. J. Med., 295:1449–1454 (1976).

    Google Scholar 

  11. A. Cohen, G. E. J. Staal, A. J. Ammann, and D. W. Martin, Jr., Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase, J. Clin. Invest., 60:491–494 (1977).

    Google Scholar 

  12. A. Cohen, R. Hirschhorn, S. D. Horowitz, A. Rubinstein, S. H. Polmar, R. Hong, and D. W. Martin, Jr., Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency, Proc. Natl. Acad. Sci., U.S.A., 75:472–476 (1978).

    Google Scholar 

  13. R. P. Creagan, J. A. Tischfield, E. A. Nichols, and F. H. Ruddle, Autosomal assignment of the gene for the form of adenosine deaminase which is deficient in patients with combined immunodeficiency syndrome, Lancet II, 1449 (1973).

    Google Scholar 

  14. N. L. Edwards, E. W. Gelfand, D. Biggar, and I. H. Fox, Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism, J. Lab. Clin. Med., 91:736–749 (1978).

    Google Scholar 

  15. N. L. Edwards, D. B. Magilavy, J. T. Cassidy, and I. H. Fox, Lymphocyte Ecto-5’-nucleotidase deficiency in agammaglobulinemia, Science, 201:628–630 (1978).

    Google Scholar 

  16. N. L. Edwards, E. W. Gelfand, L. Burk, H.-M. Dosch, and I. H. Fox, Distribution of 51-nucleotidase in human lymphoid tissues, Proc. Natl. Acad. Sci., U.S.A., 76:3474–3476 (1979).

    Google Scholar 

  17. N. L. Edwards, J. T. Cassidy, and I. H. Fox, Lymphocyte 51- nucleotidase deficiency in hypogammaglobulinemia: Clinical characteristics, Clin. Immunol, and Immunopathol., 17:76–88 (1980).

    Google Scholar 

  18. E. R. Giblett, A. J. Ammann, D. W. Wara, R. Sandamn, L. K. Diamond, Nucleoside phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity, Lancet I, 1010–1013 (1975).

    Google Scholar 

  19. H. Green and T. S. Chan, Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: Role of adenosine deaminase, Science, 182: 836 (1973).

    Article  PubMed  CAS  Google Scholar 

  20. M. Hamet, C. Griscelli, P. Cartier, J. Ballay, C. de Bruyn, and P. Hosli, A second case of inosine phosphorylase deficiency with severe T-cell abnormalities, Adv. Exp. Med. Biol., 76A: 477–480 (1977).

    Google Scholar 

  21. L. J. Gudas, A. Cohen, B. Ullman, and D. W. Martin, Jr., Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells, Somat. Cell Genet. 4:201–219 (1978).

    Google Scholar 

  22. L. J. Gudas, B. Ullman, A. Cohen, and D. W. Martin, Jr., Deoxyguanosine toxicity in a mouse T lymphoma: Relationship to purine nucleoside phosphorylase-associated immune dysfunction, Cell, 14:531–538 (1978).

    Google Scholar 

  23. M. S. Hershfield, Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthineguanin phosphoribosyltransferase-deficient patients, J. Clin. Invest., 67:696–701 (1981).

    Google Scholar 

  24. R. Hirschhorn and D. W. Martin, Jr., Enzyme defects in immunodeficiency diseases, Springer Sem. in Immunopathol., 1: 299–321 (1978).

    Google Scholar 

  25. R. Hirschhorn, F. Martiniu, and F„ S. Rosen, Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency, Clin. Immunol, and Immunopathol., 9:287–292 (1978).

    Google Scholar 

  26. R. Hirschhorn, V. Roegner, A. Rubinstein, and P. Papageorgiou, Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child, J. Clin. Invest., 65:768–771 (1980).

    Google Scholar 

  27. T. Jenkins, A. R. Rabson, G. T. Nurse, A. B. Lane, and D. A. Hopkinson, Deficiency of adenosine deaminase not associated with severe combined immunodeficiency, J. Pediatr., 89:732–736 (1976).

    Google Scholar 

  28. J. M. Johnston and N. M. Kredich, Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemmagglutinin-stimulated human lymphocytes, J. Immunol., 123:97–103 (1979).

    Google Scholar 

  29. N. M. Kredich and M. S. Hershfield, S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin, Proc. Natl. Acad. Sci., U.S.A., 76:2450–2454 (1979).

    Google Scholar 

  30. N. M. Kredich and M. S. Hershfield, S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin, Proc. Natl. Acad. Sci., U.S.A., 76:2450–2454 (1979).

    Google Scholar 

  31. G. Marone, M. Plaut, and L. M. Lichtenstein, Characterization of a specific adenosine receptor on human lymphocytes, J. Immunol., 11:2153–2159 (1978).

    Google Scholar 

  32. W. R. A. Osborne, S.-H. Chen, E. R. Giblett, W. D. Biggar, A. J. Ammann, and C. Ronald Scott, Purine nucleoside phosphoryl ase deficiency, J. Clin. Invest., 60:741–746 (1977).

    Google Scholar 

  33. S. H. Polmar, R. C. Stern, A. L. Schwartz, E. M. Wetzler, P. A. Chase, and R. Hirschhorn, Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency, N. Engl. J. Med., 295:1337 (1976).

    Google Scholar 

  34. F. Quagliata, D. Faig, M. Conklyn, and R. Silbert, Studies on the lymphocyte 51-nucleotidase in chronic lymphocyte leukemia, infectious mononucleosis, normal subpopulations, and phyto- hemagglutinin-stimulated cells, Cancer Res., 34:3197–3203 (1974).

    Google Scholar 

  35. K. C. Rich, E. Mejias, and I. H. Fox, Purine nucleoside phosphorylase deficiency: Improved metabolic and immunologic function with erythrocyte transfusions, Med. Intell., 303:973–976 (1980).

    Google Scholar 

  36. K. C. Rich, W. J. Arnold, T. Palella, and I. H. Fox, Cellular immune deficiency with autoimmune hemolytic anemia in purine nucleoside phosphorylase deficiency, Am. J. Med., 67:172–176 (1979).

    Google Scholar 

  37. A. L. Schwartz, R. C. Stern, and S. H. Polmar, Demonstration of an adenosine receptor on human lymphocytes in vitroand its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency, Clin. Immunol, and Immuno- pathol., 9:499–505 (1978).

    Google Scholar 

  38. G. E. J. Staal, J. W. Stoop, B. J. M. Zegers, L. H. Siegenbeek von Heukelom, M. J. M. van der Vlist, S. K. Wadman, and D. W. Martin, Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes, J. Clin. Invest., 65:103–108 (1980).

    Google Scholar 

  39. J. W. Stoop, B. J. M. Zegers, G. F. M. Hendrickx, L. H. Siegenbeek van Heukelom, G. E. J. Staal, P. K. de Bree, S. K. Wadman, and R. E. Ballieux, Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency, N. Engl. J. Med., 296:651–655 (1977).

    Google Scholar 

  40. L. F. Thompson, G. R. Boss, H. L. Spiegelberg, A. Bianchino, and J. E. Seegmiller, Ecto-5’-nucleotidase activity in lymphoblastoid cell lines derived from heterozygotes for congenital X-linked agammaglobulinemia, J. Immunol., 125:190–193 (1980).

    Google Scholar 

  41. B. Ullman, A. Cohen, and D. W. Martin, Jr., Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease, Cell, 9:205–211 (1976).

    Google Scholar 

  42. B. Ullman, L. J. Gudas, A. Cohen, and D. W. Martin, Jr., Deoxy- adenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease, Cell, 14:365–375 (1978).

    Google Scholar 

  43. A. R. Watson, D. I. K. Evans, H. B. Marsden, V. Miller, and P. A. Rogers, Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder, Arch. Dis. Chil., 563–565 (1981).

    Google Scholar 

  44. A. D. B. Webster, M. North, J. Allsop, G. L. Asherson, and R. W. E. Watts, Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia, Clin. Exp. Immunol., 31: 456–463 (1978).

    Google Scholar 

  45. R. L. Wortmann, B. S. Mitchell, N. L. Edwards, and I. H. Fox, Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: Role for 51-nucleotidase, Proc. Natl. Acad. Sci., U.S.A., 76:2434–2437 (1979).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Ammann, A.J. (1985). Purine Nucleotide Imbalance in Immunodeficiency Disorders. In: de Serres, F.J. (eds) Genetic Consequences of Nucleotide Pool Imbalance. Basic Life Sciences, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2449-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2449-2_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9488-7

  • Online ISBN: 978-1-4613-2449-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics